Declassified documents reveal funding for over 120 labs worldwide, sparking fierce debate and accusations of misinformation
Category: Politics
On June 12, 2026, outgoing Director of National Intelligence Tulsi Gabbard stirred controversy by releasing declassified documents that allege the United States has funded more than 120 biological laboratories across over 30 countries, including more than 40 in Ukraine. This disclosure has reignited a heated debate surrounding the existence and purpose of these facilities, which some critics argue have become a focal point of Russian disinformation campaigns. The release came just weeks before Gabbard's departure from office on June 30, 2026.
The documents, which were published by the Office of the Director of National Intelligence (ODNI), claim that certain U.S.-funded laboratories conduct research involving dangerous pathogens and gain-of-function studies—research aimed at enhancing the traits of organisms. Gabbard stated that these labs have been operating under limited oversight and that information about their existence and funding has been intentionally concealed by powerful actors. "The information surrounding the existence, history, locations, and funding of these U.S.-funded biolabs has been intentionally covered up by powerful people," she asserted.
According to Gabbard, one U.S.-funded laboratory in Ukraine was particularly concerning as it reportedly housed dangerous pathogens and was vulnerable to capture during Russia's full-scale invasion of Ukraine. She emphasized that the risks associated with such facilities could lead to catastrophic global consequences. In her statement, Gabbard accused politicians, public health officials, and members of the Biden administration of misleading the public about these labs, singling out Dr. Anthony Fauci as a key figure in this alleged cover-up.
These claims are not entirely new; they echo narratives that have circulated since the onset of the Russia-Ukraine conflict. Russian authorities have long claimed that Ukraine hosted U.S.-backed biological weapons programs, allegations that Washington, Kyiv, and international organizations have consistently denied. In fact, many of the facilities referenced in U.S. government documents were part of threat reduction programs established after the Cold War, aimed at securing former Soviet biological and chemical research infrastructure.
The release of these documents has sparked a fierce debate online, with reactions ranging from support among certain political factions to accusations of Gabbard promoting Russian propaganda. Some commentators praised her for exposing what they see as hidden truths, whereas others, including national security experts, criticized her for reviving a misleading narrative that has been debunked. Christopher Miller, a correspondent for the Financial Times, remarked, "Before she departs, Gabbard uses her platform and access to intelligence to perpetuate one of her and Russia’s favorite conspiracy theories, disingenuously twisting facts and delivering a gift to the Kremlin."
Critics like Josh Segal, an expert on biological weapons, expressed confusion over why Gabbard would release information that could lend credence to a narrative the intelligence community has labeled as disinformation. "Their labs are not now and were never secret, and do zero questionable work," Segal stated, emphasizing that U.S. cooperation with Ukrainian laboratories was a highly publicized effort aimed at enhancing biosafety and disease surveillance.
The controversy surrounding U.S. biolabs traces back to early 2022, when Russian officials first claimed that Ukraine was home to U.S.-funded biological weapons facilities. At that time, the U.S. government dismissed these claims as absurd and unfounded. Then-U.S. Ambassador to the United Nations Linda Thomas-Greenfield stated unequivocally that there were no Ukrainian biological weapons laboratories supported by the United States. Meanwhile, Victoria Nuland, then-Under Secretary of State, acknowledged the existence of biological research facilities in Ukraine but denied any U.S. ownership or operation of such labs.
In the aftermath of Gabbard's recent disclosures, some observers have pointed out that the information does not substantiate the central Russian allegation that these labs are part of a biological weapons program. Instead, the documents confirm the existence and funding of these facilities and detail the types of pathogens involved, including anthrax, Ebola, and plague. Yet, the question of whether this research constitutes a biological weapons program remains unresolved.
This situation highlights the complex interplay between national security, public health, and international relations. As Gabbard called for increased scrutiny of biological research facilities abroad, she directed intelligence agencies to expand their monitoring efforts, claiming that additional information had already been uncovered about clinical trials taking place at some of these sites. The ODNI stated that it would continue working with government partners to identify laboratories, assess their contents, and evaluate any involvement in gain-of-function research.
As the U.S. grapples with these allegations, the broader implications of Gabbard's statements and the subsequent reactions cannot be overlooked. The tension between transparency and national security remains a contentious issue, especially as misinformation continues to circulate in the digital age. Gabbard's claims have not only reignited discussions about U.S. biolabs but have also drawn attention to the challenges of combating disinformation and maintaining public trust in governmental institutions.
In the end, the revelations surrounding U.S. biolabs in Ukraine serve as a reminder of the delicate balance between scientific research and geopolitical narratives, as well as the need for continued vigilance against misinformation. The implications of Gabbard's disclosures will likely resonate beyond her tenure, shaping discussions about biosecurity and international collaboration for years to come.